Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McNeil Nicotrol Inhaler Rx test marketing.

This article was originally published in The Tan Sheet

Executive Summary

McNEIL NICOTROL INHALER Rx TEST MARKETING commenced in February in Houston, Tex. and will begin in March in Baltimore, Md. The hand-held inhaler delivers menthol-flavored nicotine to its user with each draw, mimicking the act of smoking. McNeil Consumer Products expects to launch the prescription smoking cessation product nationwide during the third or fourth quarter. The long test market may be due to the learning curve for inhaler use by consumers.

You may also be interested in...



Canadian Direct-To-OTC Sale Of Nicotine Inhaler Proposed

The Canadian Therapeutic Products Programme is soliciting comments on nonprescription availability of nicotine inhalation devices.

Canadian Direct-To-OTC Sale Of Nicotine Inhaler Proposed

The Canadian Therapeutic Products Programme is soliciting comments on nonprescription availability of nicotine inhalation devices.

Canadian Direct-To-OTC Sale Of Nicotine Inhaler Proposed

The Canadian Therapeutic Products Programme is soliciting comments on nonprescription availability of nicotine inhalation devices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088124

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel